Theriva Biologics, Inc. ( TOVX) - Stock Earnings
TOVX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 17, 2026, midnight | — / — | — | — / — | — |
TOVX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.0 million USD | — USD |
| 2026Q1 | -2.0 million USD | 300000 USD |
| 2026Q2 | -3.2 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TOVX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -18.3 million USD | — USD |
| 2024 | -25.7 million USD | — USD |
| 2025 | -25.2 million USD | — USD |
| 2026 Est. | — | — |
TOVX
Price: $0.20
52 week price:
Earnings Per Share: 1.44 USD
P/E Ratio: 0.16
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 10.3 million